COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE FOR THE TREATMENT OF SCHIZOPHRENIA IN GERMANY

被引：0
|
作者：
Zeidler, J.
Mahlich, J. C. [1 ]
Greiner, W. [2 ]
Heres, S. [3 ]
机构：
[1] Janssen Pharmaceut Co Johnson & Johnson, Neuss, Germany
[2] Univ Bielefeld, Sch Publ Hlth, D-33615 Bielefeld, Germany
[3] Tech Univ Munich, D-80290 Munich, Germany
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1403
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A547 / A547
页数：1
相关论文
共 50 条
  • [1] Cost effectiveness of paliperidone palmitate for the treatment of schizophrenia in Germany
    Zeidler J.
    Mahlich J.
    Greiner W.
    Heres S.
    [J]. Applied Health Economics and Health Policy, 2013, 11 (5) : 509 - 521
  • [2] COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE FOR THE TREATMENT OF SCHIZOPHRENIA IN MEXICO
    Reyes-Lopez, A.
    Querol, J.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A561 - A561
  • [3] Erratum to: Cost Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany
    Jan Zeidler
    Jörg Mahlich
    Wolfgang Greiner
    Stephan Heres
    [J]. Applied Health Economics and Health Policy, 2013, 11 (6) : 689 - 689
  • [4] THE COST-EFFECTIVENESS AND COST-UTILITY OF PALIPERIDONE PALMITATE IN THE TREATMENT OF SCHIZOPHRENIA IN GUATEMALA
    Obando, C. A.
    Gonzalez, L.
    Muschett, D.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A695 - A695
  • [5] COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE VERSUS OTHER ANTIPSYCHOTICS FOR THE TREATMENT OF SCHIZOPHRENIA IN FRANCE
    Doutriaux, A.
    Cognet, M.
    Druais, S.
    Lancon, C.
    Samalin, L.
    Levy, P.
    Godet, A.
    Guillon, P.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A459 - A459
  • [6] Cost-effectiveness of Paliperidone Palmitate Versus other Antipsychotics for the Treatment of Schizophrenia in France
    Doutriaux, A.
    Druais, S.
    Cognet, M.
    Lancon, C.
    Samalin, L.
    Levy, P.
    Godet, A.
    Guillon, P.
    [J]. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2015, 18 : S11 - S12
  • [7] THE COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE COMPARED TO OLANZAPINE PAMOATE IN THE TREATMENT OF SCHIZOPHRENIA IN SWEDEN
    Pudas, H.
    Hemels, M.
    Mehnert, A.
    Druais, S.
    Martin, M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A560 - A561
  • [8] A COST-EFFECTIVENESS ANALYSIS OF PALIPERIDONE PALMITATE VERSUS OLANZAPINE PAMOATE IN THE TREATMENT OF SCHIZOPHRENIA IN NORWAY
    Einarson, T. R.
    Vicente, C.
    Zilbershtein, R.
    Piwko, C.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A292 - A293
  • [9] Cost Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany (vol 11, pg 509, 2013)
    Zeidler, Jan
    Mahlich, Joerg
    Greiner, Wolfgang
    Heres, Stephan
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2013, 11 (06) : 689 - 689
  • [10] Cost-effectiveness analysis of paliperidone palmitate compared to other antipsychotics indicated for the treatment of schizophrenia in France
    Druais, S.
    Doutriaux, A.
    Cognet, M.
    Lancon, C.
    Samalin, L.
    Levy, P.
    Godet, A.
    Guillon, P.
    [J]. EUROPEAN PSYCHIATRY, 2014, 29 (08) : 653 - 653
12345